Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abanish Biswas
Observed name:
Biswas, Abanish
Institution:
Birla Institute of Technology, Mesra
Observed institution:
Birla Institute of Technology, Mesra
ORCID:
0000-0002-4871-0453
Observed ORCID:
0000-0002-4871-0453
OpenAlex ID:
A5071256393
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition
2023
·
Antonio Laghezza
, Carmen Cerchia
, et al.
·
Journal of Medicinal Chemistry
·
12
PDF
Target prediction, computational identification, and network-based pharmacology of most potential phytoconstituent in medicinal leaves of Justicia adhatoda against SARS-CoV-2
2022
·
Pankaj Dagur
, Gourav Rakshit
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
12
Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer
2023
·
Ayse Mine Yilmaz Goler
, Ayse Tarbin Jannuzzi
, et al.
·
Chemistry & Biodiversity
·
9
PDF
In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA)Inhibitors
2023
·
Gourav Rakshit
, Abanish Biswas
, et al.
·
Pathogens
·
8
PDF
A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model
2025
·
Antonio Laghezza
, Emanuele Falbo
, et al.
·
European Journal of Medicinal Chemistry
·
6
A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties
2024
·
Antonio Laghezza
, Carmen Cerchia
, et al.
·
European Journal of Medicinal Chemistry
·
6
Molecular docking and molecular dynamics in natural products-based drug discovery
2023
·
Gourav Rakshit
, Komal
, et al.
·
Elsevier eBooks
·
6
Prospects for Prostate Cancer Chemotherapy: Cytotoxic Evaluation and Mechanistic Insights of Quinolinequinones with ADME/PK Profile
2024
·
Ayse Tarbin Jannuzzi
, Ayse Mine Yilmaz Goler
, et al.
·
Biomedicines
·
5
PDF
CADD Approaches in Anticancer Drug Discovery
2023
·
Abanish Biswas
, Venkatesan Jayaprakash
·
Interdisciplinary biotechnological advances
·
5
Computational Methods in Natural Products-Based Drug Discovery
2023
·
Pankaj Dagur
, Shreya
, et al.
·
Interdisciplinary biotechnological advances
·
5
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1 – An update (2020–2025)
2025
·
Abanish Biswas
, Venkatesan Jayaprakash
·
Bioorganic & Medicinal Chemistry
·
4
Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile
2025
·
Ayse Mine Yilmaz
, Ayse Tarbin Jannuzzi
, et al.
·
Chemical Biology & Drug Design
·
2
PDF
Rational Design of Peptides and Protein Molecules in Drug Discovery
2024
·
Ipsa Padhy
, Abanish Biswas
, et al.
·
Wiley eBooks
·
2
PDF
Reimagining QSAR Modeling with Quantum Chemistry: A CYP1B1 Inhibitor Case Study
2025
·
Abanish Biswas
, Venkatesan Jayaprakash
·
1
PDF
Morpholine‐Based Chalcones as Potent and Selective MAO‐B Inhibitors With Preliminary CNS Drug‐Like Properties
2026
·
Asmar Taghiyeva
, Jaeyeop Lim
, et al.
·
ChemMedChem
Discovery of potent and selective MAO-B inhibitors from a morpholine-substituted chalcone library for neurodegenerative disorders
2026
·
Asmar Taghiyeva
, Jaeyeop Lim
, et al.
·
Molecular Diversity
Discovery of a Potent and Selective MAO‐B Inhibitor From a Donepezil‐Linked Chalcone Library With Promising Antiparkinsonian Activity
2026
·
Azize Kirac‐Aydin
, Bishnu Prasad Pandey
, et al.
·
Drug Development Research
PDF
Design, synthesis, and antimicrobial evaluation of heteroaromatic or acyl-substituted benzenesulfonamide-linked aminoquinolinequinones
2026
·
Hatice Yıldırım
, Mahmut Yıldız
, et al.
·
Folia Microbiologica
PDF
Evaluation of novel topiramate–phenolic acid conjugates as potent pancreatic α-amylase inhibitors: in vitro and in silico insights
2026
·
Ipsa Padhy
, Tripti Sharma
, et al.
·
Journal of Computer-Aided Molecular Design
Aminated Quinolinequinones With EDG(s) as a Prostate Cancer Inhibitor: Mechanistic Insights and Pharmacokinetic Limitations
2025
·
Ayse Tarbin Jannuzzi
, Ayse Mine Yilmaz
, et al.
·
Chemistry & Biodiversity
Corrigendum to “A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties” [Eur. J. Med. Chem. 275 (2024) 116567]
2025
·
Antonio Laghezza
, Carmen Cerchia
, et al.
·
European Journal of Medicinal Chemistry
Application of artificial intelligence and machine learning in natural products-based drug discovery
2023
·
Abanish Biswas
, Irina Ghosh
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
24
Citation count:
81
H-index:
6
I10-index:
2
Year
Topic
Type